Victory Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,075
| Closed | -$19K | – | 2760 |
|
|
2022
Q3 | $19K | Sell |
16,075
-2,925
| -15% | -$3.46K | ﹤0.01% | 2634 |
|
|
2022
Q2 | $34K | Buy |
19,000
+88
| +0.5% | +$157 | ﹤0.01% | 2583 |
|
|
2022
Q1 | $38K | Buy |
18,912
+1,138
| +6% | +$2.29K | ﹤0.01% | 2614 |
|
|
2021
Q4 | $48K | Buy |
17,774
+1,078
| +6% | +$2.91K | ﹤0.01% | 2644 |
|
|
2021
Q3 | $74K | Buy |
16,696
+1,372
| +9% | +$6.08K | ﹤0.01% | 2655 |
|
|
2021
Q2 | $89K | Sell |
15,324
-640
| -4% | -$3.72K | ﹤0.01% | 2612 |
|
|
2021
Q1 | $112K | Buy |
15,964
+2,056
| +15% | +$14.4K | ﹤0.01% | 2590 |
|
|
2020
Q4 | $67K | Buy |
13,908
+728
| +6% | +$3.51K | ﹤0.01% | 2442 |
|
|
2020
Q3 | $77K | Buy |
13,180
+161
| +1% | +$941 | ﹤0.01% | 2360 |
|
|
2020
Q2 | $88K | Sell |
13,019
-8,865
| -41% | -$59.9K | ﹤0.01% | 2367 |
|
|
2020
Q1 | $140K | Buy |
+21,884
| New | +$140K | ﹤0.01% | 2432 |
|
|
2019
Q4 | – | Sell |
-8,876
| Closed | -$35K | – | 3514 |
|
|
2019
Q3 | $35K | Buy |
+8,876
| New | +$35K | ﹤0.01% | 2844 |
|
|
2018
Q3 | – | Sell |
-189
| Closed | -$9K | – | 1916 |
|
|
2018
Q2 | $9K | Sell |
189
-14,440
| -99% | -$688K | ﹤0.01% | 1812 |
|
|
2018
Q1 | $772K | Buy |
14,629
+14,440
| +7,640% | +$762K | ﹤0.01% | 1289 |
|
|
2017
Q4 | $13K | Hold |
189
| – | – | ﹤0.01% | 1800 |
|
|
2017
Q3 | $16K | Hold |
189
| – | – | ﹤0.01% | 1789 |
|
|
2017
Q2 | $18K | Sell |
189
-21,204
| -99% | -$2.02M | ﹤0.01% | 1775 |
|
|
2017
Q1 | $1.36M | Buy |
21,393
+21,208
| +11,464% | +$1.35M | ﹤0.01% | 1050 |
|
|
2016
Q4 | $8K | Buy |
185
+11
| +6% | +$476 | ﹤0.01% | 1782 |
|
|
2016
Q3 | $6K | Buy |
174
+13
| +8% | +$448 | ﹤0.01% | 1771 |
|
|
2016
Q2 | $2K | Buy |
161
+4
| +3% | +$50 | ﹤0.01% | 1632 |
|
|
2016
Q1 | $3K | Buy |
157
+13
| +9% | +$248 | ﹤0.01% | 1658 |
|
|
2015
Q4 | $5K | Buy |
144
+10
| +7% | +$347 | ﹤0.01% | 1674 |
|
|
2015
Q3 | $12K | Buy |
134
+13
| +11% | +$1.16K | ﹤0.01% | 1603 |
|
|
2015
Q2 | $11K | Buy |
+121
| New | +$11K | ﹤0.01% | 1618 |
|